Manufacturer record
TammanTitoePhar ma Pvt Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by TammanTitoePhar ma Pvt Ltd (Tamil Nadu) was declared Not of Standard Quality in November 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: ME404, Metoclopramide HCL Injection IP- 2ml (exp Feb 2026). DTL Chennai (state lab) found it not of standard quality: Sample does not conform to the requirement for PH. Listed in the November 2024 alert.
Records by type
1 record linked to TammanTitoePhar ma Pvt Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metoclopramide HCL Injection IP- 2ml | Batch ME404Mfg Mar 2024 · Exp Feb 2026 | Sample does not conform to the requirement for PH.pH | DTL ChennaiState lab | Nov 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.